Lantheus Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Lantheus Holdings, Inc. (LNTH) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 570.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 570.00K shares, a 55.71% decline year-over-year.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.34M shares, a 94.67% increase year-over-year.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.86M shares, a 1193.06% increase year-over-year.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.29M shares, a 52.31% increase year-over-year.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.55M shares, a 74.19% increase from fiscal 2024.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 891.00K shares, a 111.64% increase from fiscal 2023.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 421.00K shares, a 17.60% increase from fiscal 2022.
- Lantheus Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 358.00K shares, a 87.63% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 570.00K shares 10-Q · filed 2026-08-06 | 895.00 shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 2.34M shares 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 1.55M shares 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 1.86M shares 10-Q · filed 2025-11-06 | 1.62M shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.29M shares 10-Q · filed 2026-08-06 | 1.27K shares 10-Q · filed 2026-08-06 | 1.27M shares 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | 1.20M shares 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 891.00K shares 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 144.00K shares 10-Q · filed 2025-11-06 | 855.00K shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 845.00K shares 10-Q · filed 2025-08-06 | 1.22M shares 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | 2.38M shares 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | 421.00K shares 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | 435.00K shares 10-Q · filed 2024-11-06 | 422.00K shares 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | 349.00K shares 10-Q · filed 2024-07-31 | 389.00K shares 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | 2.95M shares 10-Q · filed 2024-05-02 | ||||
| 2022-12-31 | 358.00K shares 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | 52.00K shares 10-Q · filed 2023-11-02 | 226.00K shares 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | 268.00K shares 10-Q · filed 2023-08-03 | 196.00K shares 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | 377.00K shares 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | 2.89M shares 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | 3.05M shares 10-Q · filed 2022-11-03 | 3.05M shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 3.17M shares 10-Q · filed 2022-08-04 | 3.17M shares 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 1.35M shares 10-Q · filed 2022-04-29 | ||||
| 2020-12-31 | 3.17M shares 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | 2.59M shares 10-Q · filed 2021-11-04 | 1.66M shares 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 1.65M shares 10-Q · filed 2021-07-28 | 1.52M shares 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | 604.00K shares 10-Q · filed 2021-05-04 | ||||
| 2019-12-31 | 50.00K shares 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | 48.00K shares 10-Q · filed 2020-11-05 | 44.00K shares 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | 31.00K shares 10-Q · filed 2020-07-31 | 55.00K shares 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | 222.00K shares 10-Q · filed 2020-04-30 | ||||
| 2018-12-31 | 424.00K shares 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | 355.00K shares 10-Q · filed 2019-10-31 | 346.00K shares 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | 327.00K shares 10-Q · filed 2019-07-25 | 300.00K shares 10-Q · filed 2019-07-25 | |||
| 2018-03-31 | 86.00K shares 10-Q · filed 2019-04-30 | ||||
| 2017-12-31 | 604.00K shares 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | 322.00K shares 10-Q · filed 2018-10-30 | 378.00K shares 10-Q · filed 2018-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |